Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Elife
|
June 6, 2015
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma
Arun M Unni, William W Lockwood, Kreshnik Zejnullahu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2012
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
Levi J Beverly, William W Lockwood, Parag P Shah, et al.
Science (New York, N.Y.)
|
August 30, 2008
Seeding and propagation of untransformed mouse mammary cells in the lung
Katrina Podsypanina, Yi-Chieh Nancy Du, Martin Jechlinger, et al.
Cancer Research
|
January 18, 2015
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
Xiaoling Song, Pang-Dian Fan, Amlak Bantikassegn, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
FORMATION OF MALIGNANT, METASTATIC SMALL CELL LUNG CANCERS THROUGH OVERPRODUCTION OF cMYC PROTEIN IN TP53 AND RB1 DEPLETED PULMONARY NEUROENDOCRINE CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS
Huanhuan Joyce Chen, Eric E Gardner, Yajas Shah, et al.
The Journal of Experimental Medicine
|
February 10, 2019
Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells
Huanhuan Joyce Chen, Asaf Poran, Arun M Unni, et al.
Elife
|
November 27, 2018
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Arun M Unni, Bryant Harbourne, Min Hee Oh, et al.
Elife
|
July 22, 2025
Metastatic small cell lung cancer arises from TP53/RB1-deficient and MYC overproduction hESC-derived PNECs
Huanhuan Joyce Chen, Eric E Gardner, Yajas Shah, et al.
Plos Medicine
|
March 2, 2005
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
William Pao, Vincent A Miller, Katerina A Politi, et al.
Science (New York, N.Y.)
|
November 18, 2021
Create a COVID-19 commission
Christopher F Chyba, Christine K Cassel, Susan L Graham, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Elife
|
June 6, 2015
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma
Arun M Unni, William W Lockwood, Kreshnik Zejnullahu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 12, 2012
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
Levi J Beverly, William W Lockwood, Parag P Shah, et al.
Science (New York, N.Y.)
|
August 30, 2008
Seeding and propagation of untransformed mouse mammary cells in the lung
Katrina Podsypanina, Yi-Chieh Nancy Du, Martin Jechlinger, et al.
Cancer Research
|
January 18, 2015
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
Xiaoling Song, Pang-Dian Fan, Amlak Bantikassegn, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
FORMATION OF MALIGNANT, METASTATIC SMALL CELL LUNG CANCERS THROUGH OVERPRODUCTION OF cMYC PROTEIN IN TP53 AND RB1 DEPLETED PULMONARY NEUROENDOCRINE CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS
Huanhuan Joyce Chen, Eric E Gardner, Yajas Shah, et al.
The Journal of Experimental Medicine
|
February 10, 2019
Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells
Huanhuan Joyce Chen, Asaf Poran, Arun M Unni, et al.
Elife
|
November 27, 2018
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Arun M Unni, Bryant Harbourne, Min Hee Oh, et al.
Elife
|
July 22, 2025
Metastatic small cell lung cancer arises from TP53/RB1-deficient and MYC overproduction hESC-derived PNECs
Huanhuan Joyce Chen, Eric E Gardner, Yajas Shah, et al.
Plos Medicine
|
March 2, 2005
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
William Pao, Vincent A Miller, Katerina A Politi, et al.
Science (New York, N.Y.)
|
November 18, 2021
Create a COVID-19 commission
Christopher F Chyba, Christine K Cassel, Susan L Graham, et al.
Page
of 8